Abstract
Our aim was to determine prospectively whether increased body mass index (BMI) affects endometrial receptivity through displacement of the window of implantation (dWOI) using the endometrial receptivity analysis (ERA), and whether this effect is BMI-dependent. We recruited a population of 170 infertile women with a normal uterus and no clinical history of recurrent miscarriage or implantation failure. These women were divided into four groups according to BMI: normal weight (18.5–24.9 kg/m2; n = 44), overweight (25–29.9 kg/m2; n = 29), class I obese (30.0–34.9 kg/m2; n = 54), and class II and III obese (> 35 kg/m2; n = 43). We also assigned the patients to one of two larger BMI cohorts: non-obese (normal weight and overweight; n = 73) and obese (class I, II, and III obese; n = 97). We compared analytical and clinical data and dWOI in these categories, finding significant metabolic differences in glycemia, TSH, insulin, HDL cholesterol, LDL cholesterol, triglycerides, and systolic and diastolic blood pressure among the different BMI groups. One-day dWOI increased significantly with BMI, and significant differences were observed in the non-obese versus obese categories (9.7% vs 25.3 %, respectively (p = 0.02)). dWOI was most pronounced in patients with class II–III obesity. In addition, displacement was longer as BMI increased since ERA revealed a higher proportion of displacements of 1 day than of 12 h and showed they were predominantly pre-receptive. In conclusion, obesity has a negative effect on endometrial receptivity through delaying of the WOI, which increases in function of BMI as well as the metabolic disturbances of the patient.
Similar content being viewed by others
Data Availability
Yes.
Code Availability
N/A
References
World Health Organization (WHO), 2016. Obesity and overweight: fact sheet [www document]. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed Oct 15, 2020
Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89:2583–9.
Bellver J. Obesity and poor reproductive outcome: female and male body weight matter. Fertil Steril. 2013;99:1558–9.
Zhang Y, Zhang J, Zhao J, Hong X, Zhang H, Dai O, et al. Couples’ prepregnancy body mass index and time to pregnancy among those attempting to conceive their first pregnancy. Fertil Steril. 2020;114:1067–75.
Nelson SM, Matthews P, Poston L. Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum Reprod Update. 2009;16:255–75.
Mahutte N, Kamga-Ngande C, Sharma A, Sylvestre C. Obesity and reproduction. J Obstet Gynaecol Can. 2018;40:950–66.
NCHS Data Brief No. 360, February 2020. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. https://www.cdc.gov/nchs/products/databriefs/db360.htm. Accessed Oct 15, 2020
Hassan MAM, Killick SR. Negative lifestyle is associated with a significant reduction in fecundity. Fertil Steril. 2004;81:384–92.
Polotsky AJ, Hailpern SM, Skurnick JH, Lo JC, Sternfeld B, Santoro N. Association of adolescent obesity and lifetime nulliparity—the Study of Women’s Health Across the Nation (SWAN). Fertil Steril. 2010;93:2004–11.
Wise LA, Rothman KJ, Mikkelsen EM, Sørensen HT, Rii A, Hatch EE. An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod. 2010;25:253–64.
Rich-Edwards JW, Spiegelman D, Garland M, Hertzmark E, Hunter DJ, Colditz GA, et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology. 2002;13:184–90.
Van Der Steeg JW, Steures P, Eijkemans MJC, Habbema JDF, Hompes PGA, Burggraaff JM, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008;23:324–8.
Bellver J, Ayllón Y, Ferrando M, Melo M, Goyri E, Pellicer A, et al. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010;93:447–54.
Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod. 2011;26:245–52.
Kawwass JF, Kulkarni AD, Hipp HS, Crawford S, Kissin DM, Jamieson DJ. Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States. Fertil Steril. 2016;106:1742–50.
Provost MP, Acharya KS, Acharya CR, Yeh JS, Steward RG, Eaton JL, et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry. Fertil Steril. 2016;105:663–9.
Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallo V, Colombani M, et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019;25:439–51.
Cardozo ER, Karmon AE, Gold J, Petrozza JC, Styer AK. Reproductive outcomes in oocyte donation cycles are associated with donor BMI. Hum Reprod. 2016;31:385–92.
Bellver J, Mifsud A, Grau N, Privitera L, Meseguer M. Similar morphokinetic patterns in embryos derived from obese and normoweight infertile women: a time-lapse study. Hum Reprod. 2013;28:794–800.
Bellver J, De Los Santos MJ, Alamá P, Castelló D, Privitera L, Galliano D, et al. Day-3 embryo metabolomics in the spent culture media is altered in obese women undergoing in vitro fertilization. Fertil Steril. 2015;103:1407–15.
Comstock I, Kim S, Behr B, Lathi RB. Increased body mass index negatively impacts blastocyst formation rate in normal responders undergoing in vitro fertilization. J Assist Reprod Genet. 2015;32:1299–304.
Provost MP, Acharya KS, Acharya CR, Yeh JS, Steward RG, Eaton JL, et al. Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22,317 fresh donor/recipient cycles from the 2008–2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry. Fertil Steril. 2016;105:364–8.
Bellver J, Pellicer A, García-Velasco JA, Ballesteros A, Remohí J. Meseguer M. Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors. Fertil Steril 2013;100: 1050-1058.
Insogna IG, Lee MS, Reimers RM, Toth TL. Neutral effect of body mass index on implantation rate after frozen-thawed blastocyst transfer. Fertil Steril. 2017; 108:770-776.e1.
Prost E, Reignier A, Leperlier F, Caillet P, Barriere P, Freour T, et al. Female obesity does not impact live birth rate after frozen-thawed blastocyst transfer. Hum Reprod. 2020;35:859–65.
Chen R, Chen S, Liu M, He H, Xu H, Liu H, et al. Pregnancy outcomes of PCOS overweight/obese patients after controlled ovarian stimulation with the GnRH antagonist protocol and frozen embryo transfer. Reprod Biol Endocrinol. 2018;16:36.
Qiu M, Tao Y, Kuang Y, Wang Y. Effect of body mass index on pregnancy outcomes with the freeze-all strategy in women with polycystic ovarian syndrome. Fertil Steril. 2019;112:1172–9.
Zhang J, Liu H, Mao X, Chen Q, Fan Y, Xiao Y, et al. Effect of body mass index on pregnancy outcomes in a freeze-all policy: an analysis of 22,043 first autologous frozen-thawed embryo transfer cycles in China. BMC Med. 2019;17:114.
Bellver J, Martínez-Conejero JA, Labarta E, Alamá P, Melo MAB, Remohí J, et al. Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome. Fertil Steril. 2011;95:2335–41.
Riesewijk A, Martín J, van Os R, Horcajadas JA, Polman J, Pellicer A, et al. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod. 2003;9:253–64.
Díaz-Gimeno P, Horcajadas JA, Martinez-Conejero JA, Esteban FJ, Alama P, Pellicer A, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95:50–60.
Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, Gómez E, Fernández-Sánchez M, Carranza F, et al. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertil Steril. 2013;100:818–24.
Ruiz-Alonso M, Galindo N, Pellicer A, Simón C. What a difference two days make: personalized embryo transfer (pET) paradigm: a case report and pilot study. Hum Reprod. 2014;29:1244–7.
Simon C, Gómez C, Cabanillas S, Vladimirov I, Castillón G, Giles J, et al. A 5-year multicentre randomized controlled trial comparing personalized, frozen and fresh blastocyst transfer in IVF. Reprod BioMed Online. 2020;41:402–15.
Comstock IA, Diaz-Gimeno P, Cabanillas S, Bellver J, Sebastian-Leon P, Shah M, et al. Does an increased body mass index affect endometrial gene expression patterns in infertile patients? A functional genomics analysis. Fertil Steril. 2017;107:740-8.e2
Ding W, Zhang FL, Liu XC, Hu LL, Dai SJ, Li G, et al. Impact of female obesity on cumulative live birth rates in the first complete ovarian stimulation cycle. Front Endocrinol (Lausanne). 2019;10:516.
Xue X, Shi W, Zhou H, Tian L, Zhao Z, Zhou D, et al. Cumulative live birth rates according to maternal body mass index after first ovarian stimulation for in vitro fertilization: a single center analysis of 14,782 patients. Front Endocrinol (Lausanne). 2020;11:149.
Metwally M, Tuckerman EM, Laird SM, Ledger WL, Li TC. Impact of high body mass index on endometrial morphology and function in the peri-implantation period in women with recurrent miscarriage. Reprod BioMed Online. 2007;14:328–34.
Metwally M, Preece R, Thomas J, Ledger W, Li TC. A proteomic analysis of the endometrium in obese and overweight women with recurrent miscarriage: preliminary evidence for an endometrial defect. Reprod Biol Endocrinol. 2014;12:75.
Smith CJ, Perfetti TA, Hayes AW, Berry SC. Obesity as a source of endogenous compounds associated with chronic disease: a review. Toxicol Sci. 2020;175:149–55.
Silvestris E, Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16:22.
Oróstica L, Poblete C, Romero C, Vega M. Pro-inflammatory markers negatively regulate IRS1 in endometrial cells and endometrium from women with obesity and PCOS. Reprod Sci. 2020;27:290–300.
Colicchia M, Campagnolo L, Baldini E, Ulisse S, Valensise H, Moretti C. Molecular basis of thyrotropin and thyroid hormone action during implantation and early development. Hum Reprod Update. 2014;20:884–904.
Wu Z, Cai Y, Xia Q, Liu T, Yang H, Wang F, et al. Hashimoto’s thyroiditis impairs embryo implantation by compromising endometrial morphology and receptivity markers in euthyroid mice. Reprod Biol Endocrinol. 2019;17:94.
Acknowledgements
We would like to thank all the organisms, clinicians, embryologists, and nurses involved in this work, and especially Sheila Caloto Mosteirin for her tireless work in selecting candidates for the study.
Funding
Igenomix S.L
Author information
Authors and Affiliations
Contributions
Jose Bellver and Carlos Marin equal contribution.
Corresponding author
Ethics declarations
Ethics Approval
CEIC IVI VALENCIA approved 2nd July 2014.
Consent to Participate
Done
Consent for Publication
Done
Conflict of Interest
Yes, Carlos Simon, Diana Valbuena, Carlos Marin, and Maria Ruiz-Alonso are employees of Igenomix.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 13 kb)
Rights and permissions
About this article
Cite this article
Bellver, J., Marín, C., Lathi, R.B. et al. Obesity Affects Endometrial Receptivity by Displacing the Window of Implantation. Reprod. Sci. 28, 3171–3180 (2021). https://doi.org/10.1007/s43032-021-00631-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-021-00631-1